Cargando…
Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system
Atypical femur fracture (AFF) is a rare but catastrophic adverse event first reported in the long-term use of alendronate, one of the most commonly used drugs for osteoporosis currently. However, further evidence is needed to learn more regarding other common anti-osteoporosis drugs and the risk for...
Autores principales: | Xiao, Yao, Chen, Yiqian, Huang, Yan, Xiao, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322871/ https://www.ncbi.nlm.nih.gov/pubmed/37407650 http://dx.doi.org/10.1038/s41598-023-37944-x |
Ejemplares similares
-
Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018) -
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
por: Li, Ying, et al.
Publicado: (2020) -
Bisphosphonates and Atypical Fractures of Femur
por: Yli-Kyyny, Tero
Publicado: (2011) -
Clinical features of atypical femur fracture
por: Shin, Joong Sup, et al.
Publicado: (2016) -
Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017)